Schoeck Andreas P, Mellion Michelle L, Gilchrist James M, Christian Fredric V
Department of Neurology, Rhode Island Hospital, Brown Medical School, 593 Eddy Street, APC 689, Providence, Rhode Island 02903, USA.
Muscle Nerve. 2007 Apr;35(4):521-4. doi: 10.1002/mus.20690.
Patients with implanted cardiac devices and their physicians may defer important electrodiagnostic testing because of anxiety about potential negative effects on the device. To determine the safety of routine nerve conduction studies (NCS) in this population, 10 patients with permanent dual-chamber pacemakers of various types and five patients with implanted cardiac defibrillators (ICD) underwent nerve stimulation at sites commonly used during NCS. The implanted cardiac device was interrogated before and after the study and there was continuous monitoring of the surface electrocardiogram (ECG) and atrial and ventricular electrograms. Electrical impulses generated during routine NCS were never detected by the sensing amplifier and did not affect the programmed settings of the implanted cardiac device. We conclude that routine NCS is safe in patients with implanted cardiac pacemakers with bipolar sensing configurations and defibrillators.
植入心脏设备的患者及其医生可能会因担心对设备产生潜在负面影响而推迟重要的电诊断测试。为了确定该人群中常规神经传导研究(NCS)的安全性,10名患有各种类型永久性双腔起搏器的患者和5名植入式心脏除颤器(ICD)患者在NCS期间常用的部位接受了神经刺激。在研究前后对植入的心脏设备进行了询问,并持续监测体表心电图(ECG)以及心房和心室电图。在常规NCS期间产生的电脉冲从未被传感放大器检测到,也未影响植入心脏设备的程控设置。我们得出结论,对于具有双极传感配置的植入式心脏起搏器和除颤器的患者,常规NCS是安全的。